Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole
- 26 January 1996
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 51 (2) , 187-191
- https://doi.org/10.1016/0006-2952(95)02152-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Temporal Alterations in Specific Basement Membrane Components in Lungs from Monocrotaline-treated RatsAmerican Journal of Respiratory Cell and Molecular Biology, 1993
- Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrroleToxicology and Applied Pharmacology, 1990
- Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1990
- Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of ratsToxicology and Applied Pharmacology, 1988
- Release of Soluble Fibronectin Containing an Extra Type III Domain (ED1) during Acute Pulmonary Injury Mediated by Oxidants or LeukocytesIn VivoAmerican Review of Respiratory Disease, 1988
- Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung.Journal of Clinical Investigation, 1986
- FibronectinsScientific American, 1986
- Effects of monocrotaline treatment on norepinephrine removal by isolated, perfused rat lungsBiochemical Pharmacology, 1984
- Blood Vessel Fibronectin Increases in Conjunction with Endothelial Cell Proliferation and Capillary Ingrowth During Wound HealingJournal of Investigative Dermatology, 1982
- Right ventricular hypertrophy in monocrotaline pyrrole treated ratsExperimental and Molecular Pathology, 1974